BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11677199)

  • 21. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study.
    Grainge MJ; West J; Card TR
    Lancet; 2010 Feb; 375(9715):657-63. PubMed ID: 20149425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and risk factors for lymphoma in a single-center inflammatory bowel disease population.
    Chiorean MV; Pokhrel B; Adabala J; Helper DJ; Johnson CS; Juliar B
    Dig Dis Sci; 2011 May; 56(5):1489-95. PubMed ID: 20953706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study.
    Vos AC; Bakkal N; Minnee RC; Casparie MK; de Jong DJ; Dijkstra G; Stokkers P; van Bodegraven AA; Pierik M; van der Woude CJ; Oldenburg B; Hommes DW;
    Inflamm Bowel Dis; 2011 Sep; 17(9):1837-45. PubMed ID: 21830262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.
    Bernstein CN; Blanchard JF; Houston DS; Wajda A
    Thromb Haemost; 2001 Mar; 85(3):430-4. PubMed ID: 11307809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
    Mpofu C; Watson AJ; Rhodes JM
    Cochrane Database Syst Rev; 2004; (2):CD000279. PubMed ID: 15106148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased incidence of inflammatory bowel disease in Québec residents with airway diseases.
    Brassard P; Vutcovici M; Ernst P; Patenaude V; Sewitch M; Suissa S; Bitton A
    Eur Respir J; 2015 Apr; 45(4):962-8. PubMed ID: 25406447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
    Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
    Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial occurrence of inflammatory bowel disease.
    Orholm M; Munkholm P; Langholz E; Nielsen OH; Sørensen TI; Binder V
    N Engl J Med; 1991 Jan; 324(2):84-8. PubMed ID: 1984188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological evolution of epidemiology of the inflammatory bowel diseases in a hospital of Tunis.
    Ouakaa-Kchaou A; Gargouri D; Bibani N; Elloumi H; Kochlef A; Kharrat J
    Tunis Med; 2013 Jan; 91(1):70-3. PubMed ID: 23404603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of inflammatory bowel disease in Kaunas region, Lithuania.
    Kiudelis G; Jonaitis L; Adamonis K; Žvirblienė A; Tamelis A; Kregždytė R; Kučinskienė R; Šventoraitytė J; Kupčinskas L
    Medicina (Kaunas); 2012; 48(8):431-5. PubMed ID: 23128464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease.
    Connell WR; Kamm MA; Dickson M; Balkwill AM; Ritchie JK; Lennard-Jones JE
    Lancet; 1994 May; 343(8908):1249-52. PubMed ID: 7910274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Incidence of inflammatory bowel diseases in the department of Puy-de-Dôme in 1993 and 1994. EPIMICI. Epidémiologie des Maladies Inflammatoires Cryptogenetiques de l'Intestin group].
    Flamenbaum M; Zénut M; Aublet-Cuvelier B; Larpent JL; Fabre P; Abergel A; Dapoigny M; Bommelaer G
    Gastroenterol Clin Biol; 1997; 21(6-7):491-6. PubMed ID: 9295977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total and cancer mortality in a cohort of ulcerative colitis and Crohn's disease patients: The Florence inflammatory bowel disease study, 1978-2010.
    Caini S; Bagnoli S; Palli D; Saieva C; Ceroti M; Bendinelli B; Assedi M; Masala G
    Dig Liver Dis; 2016 Oct; 48(10):1162-7. PubMed ID: 27481588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Wajda A; Blanchard JF
    Gastroenterology; 2005 Sep; 129(3):827-36. PubMed ID: 16143122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study.
    Munk EM; Pedersen L; Floyd A; Nørgård B; Rasmussen HH; Sørensen HT
    Am J Gastroenterol; 2004 May; 99(5):884-8. PubMed ID: 15128355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
    Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
    Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.